Abivax (ABVX) Shares Outstanding (Diluted) (2021 - 2026)
Abivax (ABVX) recorded Weighted Average Shares Outstanding (Diluted) of 69.53 million in Q2 2026, up 10.3% from 63.05 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Abivax (ABVX) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Starting with Q4 2021, Abivax's Weighted Average Shares Outstanding (Diluted) history includes 13 quarters.
- Annual Weighted Average Shares Outstanding (Diluted) has increased for four straight years, with a four-year compound annual growth rate of 45.6% (FY2021 to FY2025).
- Across earlier years, Weighted Average Shares Outstanding (Diluted) came in at 63.05 million in FY2024 (+46.4%), 43.07 million in FY2023 (+125.6%), 19.09 million in FY2022 (+23.5%) and 15.46 million in FY2021.
- On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased for seven consecutive quarters, with growth averaging 30.9% over the last seven quarters.
- The year-over-year growth in Weighted Average Shares Outstanding (Diluted) has ranged between 10.3% (Q4 2025) and 125.6% (Q4 2023) over the last five years.
- Per Business Quant, the preceding three quarters came in at 69.53 million (Q1 2026), 69.53 million (Q4 2025) and 63.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Abivax | 7.07 Bn | 4.69 Bn | - | 69.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.53 Mn |
| Mar 31, 2026 | 69.53 Mn |
| Dec 31, 2025 | 69.53 Mn |
| Sep 30, 2025 | 63.05 Mn |
| Jun 30, 2025 | 63.05 Mn |
| Mar 31, 2025 | 63.05 Mn |
| Dec 31, 2024 | 63.05 Mn |
| Sep 30, 2024 | 43.07 Mn |
| Jun 30, 2024 | 43.07 Mn |
| Mar 31, 2024 | 43.07 Mn |
| Dec 31, 2023 | 43.07 Mn |
| Dec 31, 2022 | 19.09 Mn |
| Dec 31, 2021 | 15.46 Mn |
API Access
Abivax Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ABVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();